A study conducted by Duke-NUS Medical School and the Institute of Mental Health (IMH) in Singapore suggests that symptoms of anxiety and depression in the post-peak pandemic era could be costing the city-state 2.9 per cent of its gross domestic product (GDP), or nearly SGD 16 billion.
Tag: NUS
Meet Singapore’s new MasterChef winner Johnathan Chew
After months of challenges and an exhilarating final evening of culinary showmanship, dental student Johnathan Chew has been crowned MasterChef Singapore in Season Three of the show.
Indian comedian Zakir Khan set to return to Singapore
LA Comedy Live welcomes back its first indian comedian Zakir Khan to Singapore on June 25 at the National University of Singapore.
Grew up exposed to socio-cultural diversity of South Asia, says ISAS director Professor Iqbal Singh Sevea
Singaporean-Indian Professor Iqbal Singh Sevea took charge as the director of the Institute of South Asian Studies (ISAS) at National University of Singapore (NUS) on January 1. Catch his exclusive interview with Connected to India.
Harvard tops US News Global Universities Ranking 2022; NUS, NTU 2nd and 3rd in Asia
The NUS and NTU ranked second and third in Asia in the Harvard top US News & World Report of the Best Global Universities rankings.
Incoming dean of NUS Law ‘relinquishes appointment’ 2 weeks after announcement due to personal reasons
Incoming dean of National University of Singapore Faculty of Law Professor Hans Tjio has relinquished his appointment for personal reasons. Professor Simon Chesterman will continue as Dean of the Faculty of Law for a fourth term, said a news release by NUS.
NUS researchers develop foldable tent for safe dental care during pandemic
As dentists are at a high risk of exposure to COVID-19, and other critical infectious diseases, researchers from National University Singapore have invented a portable tent-like shield to prevent the spread of saliva and aerosols generated during dental procedures.
NUS researchers derive optimal drug combination against COVID-19 using AI
NUS researchers found that the optimal drug therapy was a combination of the drugs remdesivir, ritonavir, and lopinavir at specific doses.
NUS-affiliated company develops 60-second test for COVID-19
In a pilot clinical trial that involved 180 patients, the test kit achieved more than 90 per cent accuracy.
First human trial in Singapore for COVID-19 vaccine to begin soon: Duke-NUS
In a press statement, Duke-NUS Medical School said its Clinical Trial Application for the COVID-19 vaccine candidate LUNAR-COV19 has been approved to proceed by the Health Sciences Authority (HSA).